1. Clinicopathological patterns and survival outcomes of colorectal cancer among young adults in Malaysia: an institutional cohort study
- Author
-
Sui-Weng Wong, Keat Seong Poh, Mohamed Rezal Abdul Aziz, Ro-Wan Chong, Dao-Yao Ling, April Camilla Roslani, Ri-Qi Yeow, and Nora Abdul Aziz
- Subjects
Adult ,Male ,Oncology ,medicine.medical_specialty ,Colorectal cancer ,Kaplan-Meier Estimate ,Cohort Studies ,Young Adult ,Internal medicine ,medicine ,Overall survival ,Humans ,Young adult ,neoplasms ,Survival analysis ,Neoplasm Staging ,Retrospective Studies ,business.industry ,Advanced stage ,Malaysia ,Mean age ,General Medicine ,Middle Aged ,Prognosis ,medicine.disease ,digestive system diseases ,Treatment modality ,Female ,Colorectal Neoplasms ,business ,Cohort study - Abstract
INTRODUCTION This study aimed to investigate the clinicopathological patterns and survival outcomes of patients with young-onset colorectal cancer (CRC) in Malaysia. METHODS A total of 206 patients with young-onset CRC (age < 50 years at diagnosis) and 1,715 patients with late-onset CRC (age ≥ 50 years at diagnosis) diagnosed during 2002–2016 were included. The clinicopathological characteristics of patients with young-onset CRC were compared with those of patients with late-onset CRC during 2009–2013. Kaplan-Meier survival analysis was performed to determine the overall survival (OS) and disease-specific survival (DSS) in these patients. RESULTS The overall proportion of young-onset CRC was 10.7%. The mean age for young-onset CRC was 39.5 ± 7.4 years, with a male-to-female ratio of 1.2:1. There were more Malay patients with young-onset CRC than late-onset CRC (44.0% vs. 19.9%, p = 0.004). Most CRCs were diagnosed at an advanced stage in both groups. However, young-onset CRC showed more aggressive tumour characteristics, such as poorer differentiation and mucinous subtype. Despite such differences, the OS and DSS in both groups were similar (five-year OS for young-onset CRC vs. late-onset CRC: 44.2% vs. 49.0%, p = 0.40; five-year DSS for young-onset CRC vs. late-onset CRC: 48.8% vs. 57.6%, p = 0.53; mean survival of young-onset CRC vs. late-onset CRC: 4.9 years vs. 5.4 years, p = 0.15). Advanced stage at diagnosis and the treatment modality used were independent prognostic factors. CONCLUSION The unique ethnic and histological differences between patients with young- and late-onset CRC suggest that young-onset CRC may represent a distinct entity. However, despite such differences, both groups were equivalent.
- Published
- 2021
- Full Text
- View/download PDF